TQ-B3525

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for TQ-B3525, covering 2020-04-21 to 2022-03-17. Get the full timeline:

Most recent: Clinical Trial Update: TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]

See pricing